TRAVERE THERAPEUTICS, INC.: capex
| Value | {"amount": 601000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-06-30 |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3f0f01c1-8a30-4938-ac10-09ea5e85070c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001438533-18-000028Retrieved: 2026-08-19T14:10:36.228718+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/capex/2018-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3f0f01c1-8a30-4938-ac10-09ea5e85070c
History
- no predecessors — first report